FranciscoMirandaMD

Internal Medicine • Miami, FL

Physician

Join to view full profile

Dr. Miranda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Miranda's full profile

Already have an account?

Office
7306 SW 117th Ave
Miami, FL 33183
Phone+1 305-220-0220

Fax+1 866-285-7068

Education & Training

Canton Medical Education Foundation/NEOMEDResidency, Internal Medicine, 1988 - 1991
Universidad Autonoma de Nicaragua Faculty of MedicineClass of 1977

Certifications & Licensure

FL State Medical License 1990 - 2026
OH State Medical License 1991 - 2018
NJ State Medical License 1966 - 2015
TX State Medical License 1995 - 1996

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) Start of enrollment: 2014 Feb 01
Terminated
Phase 4
A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2014 Apr 01
Terminated
Phase 2
12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
Completed
Phase 3
A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
Completed
Phase 2
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers Start of enrollment: 2016 Nov 01
Unknown status
Phase 2
A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Completed
Phase 2
Join now to see all